共 50 条
- [1] Adalimumab maintains clinical remission and response in patients with active Crohn's disease: Results of the CHARM trial [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S458 - S458
- [7] Adalimumab induces and maintains remission in severe, resistant paediatric Crohn disease [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2008, 46 (02): : 208 - 211